Financial impact of adult living donation

Liver Transplantation

Volumn 9, Issue 10 SUPPL. 2, 2003, Pages

  Russo, Mark W ^a,b   Brown Jr , Robert S ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b College of Physicians/Surgeons ^*  (United States)

^c New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; AGE; ARTICLE; COST; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EVALUATION; FINANCIAL MANAGEMENT; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; SOCIAL ASPECT;

EID: 0142217432     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50228     Document Type: Article

References (26)

1. Faust D, Rabenau HF, Allwinn R, Caspary WF, Zeuzem S. Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation. Clin Transplant 2003;17:254-258.
2. Das A. Cost-effectiveness of different strategies of cytomegalovirus prophylaxis in orthotopic liver transplant recipients. Hepatology 2000;31:311-317.
3. Petitti DB. Advanced Cost Effectiveness Analysis. In: Meta-analysis, decision analysis, and cost-effectiveness analysis. Kelsey JL, Marmot MG, Stolley PD, Vessey MP, eds. Oxford University Press: New York; 1994.
4. Evans RW, Kitzmann DJ. An economic analysis of kidney transplantation. Surg Clin North Am 1998;78:149-174.
5. Jacobs C, Johnson E, Anderson K, Gillingham K, Matas A. Kidney transplants from living donors: How donation affects family dynamics. Adv Renal Transpl Ther 1998;5:89-97.
6. Smith CR, Woodward RS, Cohen DS, Singer GG, Brennan DC, Lowell J, et al. Cadaveric versus living-donor kidney transplantation: A Medicare payment analysis. Transplantation 2000; 69:311-314.
7. Kim WR. The burden of hepatitis C in the United States. Hepatology 2002;36:(suppl 1):S30-34.
8. Russo MW, Zacks SL, Sandler, RS, Brown RS Jr. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt versus endoscopic therapy for the prevention of esophageal variceal bleeding. Hepatology 2000;31:358-363.
9. Gilbert JR, Pascual M, Schoenfeld DA, Rubin RH, Delmonico FL, Cosimi AB. Evolving trends in liver transplantation: An outcome and charge analysis. Transplantation 1999;67:246-253.
10. Evans RW, Manninen DL, Dong FB. An economic analysis of liver transplantation. Costs, insurance coverage, and reimbursement. Gastroenterol Clin North Am 1993;22:451-473.
11. Best JH, Veenstra DL, Geppert J. Trends in expenditures for Medicare liver transplant recipients. Liver Transpl 2001;7:858-862.
12. Russo MW, Sandler RS, Mandelkehr L, Fair JH, Johnson MW, Brown RS Jr. Payer status, not race, affects the cost of liver transplantation. Liver Transpl Surg 1998;4:370-377.
13. Brown RS Jr, Lake JR, Ascher NL, Emond JC, Roberts JP. Predictors of the cost of liver transplantation. Liver Transpl Surg 1998;4:170-176.
14. Taylor MC, Greig PD, Detsky AS, McLeod RS, Abdoh A, Krahn MD. Factors associated with the high cost of liver transplantation adults. Can J Surg 2002;45:425-434.
15. Brown RS Jr, Ascher NL, Lake JR, Emond JC, Bacchetti P, Randall HB, Roberts JP. The impact of surgical complications after liver transplantation on resource utilization. Arch Surg 1997;132:1098-1103.
16. Whitting JF, Martin J, Zavala E, Hanto D. The influence of clinical variables on hospital costs after orthotopic liver transplantation. Surgery 1999;125:217-222.
17. Rufat P, Fourquet F, Conti F, Le Gales C, Houssin D, Coste J. Costs and outcomes of liver transplantation in adults: A prospective, 1-year, follow-up study. Transplantation 1999;68:76-83.
18. Markmann JF, Markmann JW, Markmann DA, Bacquerizo A, Singer J, Holt CD, et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation 2001;72:1113-1122.
19. Sagmeister M, Mullhaupt B, Kadry Z, Kullak-Ublick GA, Clavien PA, Renner EL. Cost-effectiveness of cadaveric and living-donor liver transplantation. Transplantation 2002;73:616-622.
20. Trotter JF, Mackenzie S, Wachs M, Bak T, Steinberg T, Polsky P, et al. Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation. Transplantation 2003;75:473-476.
21. Brown RS Jr, Russo MW, Lai M, Shiffman ML, Richardson MC, Everhart JE, Hoofnagle JH. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003;348:818-825.
22. Trotter JF, Wachs M, Trouillot T, Steinberg T, Bak T, Everson GT, Kam I. Evaluation of 100 patients for living donor liver transplantation. Liver Transpl 2000;6:290-295.
23. Trotter JF, Talamantes M, McClure M, Wachs M, Bak T, Trouillot T, et al. Right hepatic lobe donation for living donor liver transplantation: Impact on donor quality of life. Liver Transpl 2001;7:485-493.
24. Spital A, Jacobs C. Life insurance for kidney donors: Another update. Transplantation 2002;74:972-973.
25. Spital A, Kokmen T. Health insurance for kidney donors: How easy is it to obtain? Transplantation 1996;62:1356.
26. Jacobs C, Thomas C. Financial considerations in living organ donation. Progress Transpl 2003;13:130-136.